About us
Our Team
Our Board of Directors
Our Collaborations
Technology
Manufacturing
pipeline
Ocular diseases
CNS
News
Press Releases
Careers
Contact
About us
Our Team
Our Board of Directors
Our Collaborations
Technology
Manufacturing
pipeline
Ocular diseases
CNS
News
Press Releases
Careers
Contact
Home
Press Releases
Careers
Press Releases
9 June 2022
Coave Therapeutics and ABL enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy
Read more
3 May 2022
Coave Therapeutics to Present Data on its Chemically Engineered AAV Vectors for Gene Therapy in CNS Disease at ASCGT
Read more
27 April 2022
Coave Therapeutics will be presenting an abstract at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held in Denver, Colorado 1-4 May 2022. The meeting will also be available for virtual attendees 11-12 May.
Read more
13 April 2022
Coave Therapeutics to Present at Cell & Gene Meeting on the Mediterranean
Read more
15 November 2021
Coave Therapeutics Strengthens Leadership Team with the Appointments of Thomas Blaettler MD as Chief Medical Officer and Patricia Françon PhD as Chief Operating Officer
Read more
12 October 2021
Coave Therapeutics appoints Olivier Danos and Frederic Chereau as non-executive directors to its Board
Read more
16 September 2021
Coave Therapeutics and Théa Open Innovation sign exclusive licensing, co-development and commercialization agreement for Europe for CTx-PDE6b, a novel gene therapy candidate in retinitis pigmentosa
Read more
21 July 2021
Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform
Read more
WordPress Cookie Plugin by Real Cookie Banner